Tue, September 4, 2018
Fri, August 31, 2018
Thu, August 30, 2018
Wed, August 29, 2018
Tue, August 28, 2018

Adam Walsh Maintained (ASND) at Strong Buy with Decreased Target to $81 on, Aug 30th, 2018

Adam Walsh of Stifel, Maintained "Ascendis Pharma A/S" (ASND) at Strong Buy with Decreased Target from $85 to $81 on, Aug 30th, 2018.

Adam has made no other calls on ASND in the last 4 months.



There is 1 other peer that has a rating on ASND. Out of the 1 peers that are also analyzing ASND, 0 agree with Adam's Rating of Hold.



This is the rating of the analyst that currently disagrees with Adam


  • Michelle Gilson of "Canaccord Genuity" Initiated at Strong Buy and Held Target at $81 on, Tuesday, August 7th, 2018